CRP and metabolic syndrome: Importantly, PsA patients not taking disease modifying anti-rheumatic drugs (DMARDs) were twice as likely to have MetS compared to PsO patients even after adjusting by age, CRP and blood pressure (adjusted OR: 2.09, 95% CI: 0.78–5.59) (19).